Revise pharmaceutical legislation, or long-term access to medical breakthroughs for Europeans will be harmed
EFPIA, its member companies and the European Commission share the goals of increasing patient access to medicines across Europe and strengthening the competitiveness of Europe’s pharmaceutical sector. However, the proposed legislation as currently set out will have the opposite effect.